Dr. Jordan R. Plews, PhD, Co-Founder & CEO of Elevai Labs, Inc, was recently a guest on Benzinga's All Access.

Elevai is a medical aesthetic biotechnology company that develops innovative skincare products and treatments tied to obesity and metabolic health. The company's biotech division is currently developing EL-22, designed to help users of drugs like Ozempic keep lean muscle mass as they lose weight.

The company recently released preclinical data showing promising results for EL-22.